Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
10.3350/cmh.2024.0989
Author:
Woo Hyun PAIK
1
;
Do Hyun PARK
Author Information
1. Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
Publication Type:Correspondence
From:Clinical and Molecular Hepatology
2025;31(2):e158-e160